The FDA has a new warning on this medicine against blood pressure
This common medicine is subject to a new reminder of serious concerns about its security.
If you haveHypertension, you are far from being alone. According to disease control and prevention centers (CDC), about45% of Americans have been diagnosed with hypertension or take medication for the condition. However, if you take a particular type of blood pressure medications, your health could be at risk, now that it is subject to a new reminder.
On March 24, the Food and Drug Administration (FDA) announced the voluntary recall ofTelmisartan tablets from 20 mg of Alembic Pharmaceuticals, Inc.. The reminder is specific to a single batch of the product, which is found in bottles of 30 accounts and bear NDC number 62332-087-30 and lot number 1905005661 on the package. The affected bottles are also printed with an expiry date of 2022.
The medicine against blood pressure has been recalled after discovering that bottles may contain 40 mg pills instead of 20 mg pills, as well as potentially compromise the health and safety of those who take them. According to the opinion of the FDA, "patients who can be on a double dose of Telmisartan for a long period of time could undergo low blood pressure, aggravation of renal function or elevation of potassium that can be threatening life."
While the Aldemural manufacturer pharmaceuticals had not encountered any relation of adverse effects when the reminder notification was issued, the company recommends that anyone with one of the affected bottles at home speaks to their doctor or pharmacist, But should not stop taking the medicine unless a health professional tells them to do it.
If you have home batch pills, you can call alignic pharmaceuticals at 908-552-5839 weekdays from 9am to 5 hours. And or email [email protected] with questions.
Alembic is not the only company to recently draw its market medications. Read it to find out which other requirements could put your well-being at risk. And for more security risks to avoid,If you eat this for breakfast, stop immediately, said FDA.
1 EVRYSDI
On March 18, the Consumer Products Safety Board (CPSC) announced theReminder of 14,000 Genentech-Manufactured Evrysdi units, a prescription drug used to treat spinal muscle atrophy (SMA). The recall, which is specific to the 100 ml bottles of the printed medicine with NDC Number 20242-175-07 on the label, was initiated after the Genentech has received 26 freed bottles. If you have one of theaffected bottles at home,Contact Genentech For a replacement, and store any remaining medicine out of the reach of children. If the drug reaches your skin or in your eyes, the CPSC recommends washing the skin with soap and water, or rinse the drugs out of your eyes with water alone. And for the latest reminder news delivered directly to your inbox,Sign up for our daily newsletter.
2 Phenylephrine hydrochloride
Whether you are a clinician with the job at work or you use it at home, if you have aPhenylephrine hydrochloride bottle In your possession, you would be wise to check the bottle before using it. On March 11, the FDA announced that concentrations of 10 mg / ml of phenylphrine hydrochloride injections - generally used to treat low blood pressure related to the administering of anesthesia - products by SAGENT Pharmaceuticals hadrecalled because of contamination concerns related to loose packaging joints.
The recalled drugs have NDC number 25021-315-01, PHT8IB2, pht9ib2 or pht1jb2 lot numbers and expiration dates of 08/2022 or 09/2022 printed on the package. If you have the medicine concerned in your home or workplace, you can contact the shipping line of SAGENT PHARMACEUTICALS at (866) 625-1618 weekdays from the week from 8h to 7 o'clock. CT or their line of medical questions at 866-625-1618. You can alsoFill out a form on the company's website Initiate the return of the drug. In the meantime, the FDA recommends that you do not use drugs from the affected lots.
3 Spironolactone
Four a lot ofBryant Ranch Prepare spironolactone tablets In assays of 25 mg and 50 mg were recalled on March 9 after being discovered that they had been incorrect labeled, theFDA reports. The recall notice indicates that 25 mg tablets may have been placed in 50 mg packaging, and vice versa, which potentially causes some patients to obtain half of their usual dose and some of the usual dose twice.
If your tablets are printed with lot numbers 148969, 148791, 148991 and an expiration date of the expiration of July 31, 2022 148992 and May 31, 2022 Expiry Date, call Bryant Ranch Preparation at 877-885-0882 For information on how to return the medicine. And for more ways to protect yourself,If you receive this message from Pfizer, do not answer, say managers.
4 Dr. Reddy Drugs
On February 21, CPSP announced that the pharmaceutical company, Dr. Reddy's hadRecalled 21,400 prescription drug packages After discovering that their packaging was not sufficiently resistant to children. Reminder medications are 100 mg mesylate tablets of imatinib, 400 mg mesylate tablets, 50 mg pregabaline capsules, 75 mg pregabaline capsules, pregabaline capsules of 100 MG, pregabaline capsules of 150 mg, 100 mg carbonate of 100 mg of sevelamer carbonate tablets, 5 mg tablets of Tadalafil and tablets of 20 mg tadalafil.
To determine if the drugs you use or not are included in the reminder, the CSPC hasVisuals of all the packages of products concerned on its website. Initiate a refund, contact Dr. Reddy's 888-375-3784 or via theDr. Reddy's website And keep the medications somewhere that children can not access it, the CPSC recommends. And for another reminder that can affect your health,If you have this bottled water at home, stop it from drinking it now, says FDA.